DocuSign has undergone close to 20% correction from recent highs on concerns around growth saturation. Read why I think DOCU ...

The IDC MarketScape report also states, "Docusign CLM is recognized for its user-friendly experience, strong security controls, and the ability to support collaboration and version control across the ...

DocuSign’s stock price has taken a beating over the past six months, shedding 21.1% of its value and falling to $69.33 per ...

A number of stocks jumped in the afternoon session after the SaaS sector continued to rally as favorable inflation data bolstered hopes for a Federal Reserve interest rate cut. This optimism was ...

Duquesne Family Office's lead investor dumped two of the most prominent AI stocks for a company that thrived during the COVID-19 pandemic.

Instead of chasing stocks that are running to new highs, here's a method for scooping up beaten-down stocks that are trading ...

Adobe ADBE shares have declined 9% in the past month. ADBE shares have plunged 25% year to date (YTD), underperforming the ...

Surrey’s mayor says the city won’t be intimidated after a second shooting at Kap’s Café, owned by Bollywood star Kapil Sharma ...

DocuSign CEO Allan Thygesen explains how the company is leveraging its brand recognition and GenAI capabilities to solve ...

Docusign (Nasdaq:DOCU), the Intelligent Agreement Management company, today unveiled new AI-powered tools-including AI ...

DocuSign (DOCU) and Asana (ASAN) are among the software-as-a-service companies that could see some upside in the coming ...

HC Wainwright initiates Ultragenyx at Buy with $80 target, citing strong rare disease pipeline and late-stage data expected by year-end.